The multisociety collaboration moves the focus from procedures to a continuum of care from diagnosis to any treatment ...

Finding the cause of angina in patients without obstructed coronaries can reassure patients and lead to tailored therapy.

A minority of studies used the standard three-point MACE endpoint, and many tweaked their endpoints along the way.

The device has evolved from one aimed at just functional MR to a broader HF therapy. EMPOWER will provide more insights.

Gregg Stone cast doubt on its reliability in trials, while David Cohen said QoL matters to patients and should be measured.

If validated prospectively, the findings could be ‘transformative’ for patients with no current medical options.

Merging interventional and AHFTC training programs would be a boon for patients and the HF subspecialty, experts argue.

Demystifying the AED, and training a generation of kids in their use, is key to prevent “catastrophic” sudden deaths in young ...

The instructions for use have been updated to address issues that led to a greater risk of neurovascular events in an early ...

The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.

The complications portend a rise in the arrhythmia, and also in mortality, with an average time to event of 7 years.